New insights on the viral and host factors contributing to the airway pathogenesis caused by the respiratory syncytial virus

Critical Reviews in Microbiology

Volumn 42, Issue 5, 2016, Pages 800-812

  Lay, Margarita K ^a   Bueno, Susan M ^a,b   Gálvez, Nicolás ^a   Riedel, Claudia A ^c   Kalergis, Alexis M ^a,b,d  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b INSERM   (France)

^c UNIVERSIDAD ANDRÉS BELLO   (Chile)

^d PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Airways; nonstructural protein 2; respiratory syncytial virus; TSLP; viral entry

Indexed keywords

CHEMOKINE; CYTOKINE; HOST FACTOR; NONSTRUCTURAL PROTEIN 2; PATTERN RECOGNITION RECEPTOR; THYMIC STROMAL LYMPHOPOIETIN; VIRUS PROTEIN; VIRAL PROTEIN;

ASTHMA; CYTOKINE RESPONSE; EPITHELIUM CELL; HOST RESISTANCE; HUMAN; IMMUNOPATHOGENESIS; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY EPITHELIUM; RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVIEW; VIRUS ENTRY; VIRUS IMMUNITY; VIRUS PATHOGENESIS; ANIMAL; GENETICS; HOST PATHOGEN INTERACTION; HUMAN RESPIRATORY SYNCYTIAL VIRUS; METABOLISM; RESPIRATORY SYSTEM; VIROLOGY;

ANIMALS; HOST-PATHOGEN INTERACTIONS; HUMANS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RESPIRATORY SYSTEM; VIRAL PROTEINS;

EID: 84979519955     PISSN: 1040841X     EISSN: 15497828     Source Type: Journal    
DOI: 10.3109/1040841X.2015.1055711     Document Type: Review

References (149)

1. J.H.Aberle, S.W.Aberle, M.N.Dworzak,. (1999). Reduced interferon-gamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease. Am J Respir Crit Care Med 160:1263–8
2. M.Abu-Harb, F.Bell, A.Finn,. (1999). IL-8 and neutrophil elastase levels in the respiratory tract of infants with RSV bronchiolitis. Eur Respir J 14:139–43
3. D.J.Adamko, M.Friesen. (2012). Why does respiratory syncytial virus appear to cause asthma? J Allergy Clin Immunol 130:101–2
4. W.Aherne, T.Bird, S.D.Court,. (1970). Pathological changes in virus infections of the lower respiratory tract in children. J Clin Pathol 23:7–18
5. M.N.Ajuebor, R.J.Flower, R.Hannon,. (1998). Endogenous monocyte chemoattractant protein-1 recruits monocytes in the zymosan peritonitis model. J Leukoc Biol 63:108–16
6. R.Arnold, W.Konig. (2005). Respiratory syncytial virus infection of human lung endothelial cells enhances selectively intercellular adhesion molecule-1 expression. J Immunol 174:7359–67
7. M.Baggiolini, A.Walz, S.L.Kunkel. (1989). Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84:1045–9
8. A.Bardach, L.Rey-Ares, M.L.Cafferata,. (2014). Systematic review and meta-analysis of respiratory syncytial virus infection epidemiology in Latin America. Rev Med Virol 24:76–89
9. A.Baum, A.Garcia-Sastre. (2010). Induction of type I interferon by RNA viruses: cellular receptors and their substrates. Amino Acids 38:1283–99
10. J.Beale, A.Jayaraman, D.J.Jackson,. (2014). Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation. Sci Transl Med 6:256ra134
11. J.F.Bermejo-Martin, M.C.Garcia-Arevalo, R.O.De Lejarazu,. (2007). Predominance of Th2 cytokines, CXC chemokines and innate immunity mediators at the mucosal level during severe respiratory syncytial virus infection in children. Eur Cytokine Netw 18:162–7
12. R.Bonecchi, G.Bianchi, P.P.Bordignon,. (1998). Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 187:129–34
13. L.Bont, C.J.Heijnen, A.Kavelaars,. (1999). Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis. Eur Respir J 14:144–9
14. S.Bose, M.Basu, A.K.Banerjee. (2004). Role of nucleolin in human parainfluenza virus type 3 infection of human lung epithelial cells. J Virol 78:8146–58
15. S.Boyoglu-Barnum, K.A.Gaston, S.O.Todd,. (2013). A respiratory syncytial virus (RSV) anti-G protein F(ab')2 monoclonal antibody suppresses mucous production and breathing effort in RSV rA2-line19F-infected BALB/c mice. J Virol 87:10955–67
16. M.Breindahl. (2012). Cytokine responses in infants infected with respiratory syncytial virus. Open J Immunol 2:40–8
17. S.M.Bueno, P.A.Gonzalez, K.M.Cautivo,. (2008a). Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG. Proc Natl Acad Sci USA 105:20822–7
18. S.M.Bueno, P.A.Gonzalez, R.Pacheco,. (2008b). Host immunity during RSV pathogenesis. Int Immunopharmacol 8:1320–9
19. S.M.Bueno, P.A.Gonzalez, C.A.Riedel,. (2011). Local cytokine response upon respiratory syncytial virus infection. Immunol Lett 136:122–9
20. A.N.Casola, T.Burger, M.Liu,. (2001). Oxidant tone regulates RANTES gene expression in airway epithelial cells infected with respiratory syncytial virus. Role in viral-induced interferon regulatory factor activation. J Biol Chem 276:19715–22
21. C.Cayrol, J.P.Girard. (2014). IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Curr Opin Immunol 31C:31–7
22. P.F.Cespedes, S.M.Bueno, B.A.Ramirez,. (2014). Surface expression of the hRSV nucleoprotein impairs immunological synapse formation with T cells. Proc Natl Acad Sci USA 111:E3214–23
23. T.H.Chang, J.Segovia, A.Sabbah,. (2012). Cholesterol-rich lipid rafts are required for release of infectious human respiratory syncytial virus particles. Virology 422:205–13
24. X.Chen, D.M.Kube, M.J.Cooper, P.B.Davis. (2008). Cell surface nucleolin serves as receptor for DNA nanoparticles composed of pegylated polylysine and DNA. Mol Ther 16:333–42
25. P.L.Collins, J.A.Melero. (2011). Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years. Virus Res 162:80–99
26. B.E.Correia, J.T.Bates, R.J.Loomis,. (2014). Proof of principle for epitope-focused vaccine design. Nature 507:201--6
27. Daley D, Park JE, He JQ, et al. (2012). Associations and interactions of genetic polymorphisms in innate immunity genes with early viral infections and susceptibility to asthma and asthma-related phenotypes. J Allergy Clin Immunol 130:1284--93
28. M.J.De Veer, M.Holko, M.Frevel,. (2001). Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol 69:912–20
29. J.P.Devincenzo. (2004). Natural infection of infants with respiratory syncytial virus subgroups A and B: a study of frequency, disease severity, and viral load. Pediatr Res 56:914–17
30. B.Dewald, B.Moser, L.Barella,. (1992). IP-10, a gamma-interferon-inducible protein related to interleukin-8, lacks neutrophil activating properties. Immunol Lett 32:81–4
31. S.S.Diebold, T.Kaisho, H.Hemmi,. (2004). Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303:1529–31
32. J.A.Espinoza, K.Bohmwald, P.F.Cespedes,. (2013). Impaired learning resulting from respiratory syncytial virus infection. Proc Natl Acad Sci USA 110:9112–17
33. J.M.Farber. (1997). Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol 61:246–57
34. E.H.Fleming, A.A.Kolokoltsov, R.A.Davey,. (2006). Respiratory syncytial virus F envelope protein associates with lipid rafts without a requirement for other virus proteins. J Virol 80:12160–70
35. M.E.Fuentes, S.K.Durham, M.R.Swerdel,. (1995). Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. J Immunol 155:5769–76
36. S.W.Gan, L.Ng, X.Lin,. (2008). Structure and ion channel activity of the human respiratory syncytial virus (hRSV) small hydrophobic protein transmembrane domain. Protein Sci 17:813–20
37. R.Garofalo, F.Mei, R.Espejo,. (1996). Respiratory syncytial virus infection of human respiratory epithelial cells up-regulates class I MHC expression through the induction of IFN-beta and IL-1 alpha. J Immunol 157:2506–13
38. P.A.Gonzalez, S.M.Bueno, L.J.Carreno,. (2012). Respiratory syncytial virus infection and immunity. Rev Med Virol 22:230–44
39. P.A.Gonzalez, S.M.Bueno, C.A.Riedel, A.M.Kalergis. (2009). Impairment of T cell immunity by the respiratory syncytial virus: targeting virulence mechanisms for therapy and prophylaxis. Curr Med Chem 16:4609–25
40. P.A.Gonzalez, C.E.Prado, E.D.Leiva,. (2008). Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells. Proc Natl Acad Sci USA 105:14999–5004
41. M.Goritzka, L.R.Durant, C.Pereira,. (2014). Alpha/beta interferon receptor signaling amplifies early proinflammatory cytokine production in the lung during respiratory syncytial virus infection. J Virol 88:6128–36
42. C.M.Greene, T.P.Carroll, S.G.Smith,. (2005). TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells. J Immunol 174:1638–46
43. L.Gu, S.Tseng, R.M.Horner,. (2000). Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404:407–11
44. M.D.Gunn, N.A.Nelken, X.Liao, L.T.Williams. (1997). Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation. J Immunol 158:376–83
45. H.Guo-Parke, P.Canning, I.Douglas,. (2013). Relative respiratory syncytial virus cytopathogenesis in upper and lower respiratory tract epithelium. Am J Respir Crit Care Med 188:842–51
46. U.Haberstroh, K.Stilo, J.Pocock,. (1998). L-arginine suppresses lipopolysaccharide-induced expression of RANTES in glomeruli. J Am Soc Nephrol 9:203–10
47. J.Han, A.Dakhama, Y.Jia,. (2012). Responsiveness to respiratory syncytial virus in neonates is mediated through thymic stromal lymphopoietin and OX40 ligand. J Allergy Clin Immunol 130:1175–1186 e9
48. J.Holguera, E.Villar, I.Munoz-Barroso. (2014). Identification of cellular proteins that interact with Newcastle Disease Virus and human Respiratory Syncytial Virus by a two-dimensional virus overlay protein binding assay (VOPBA). Virus Res 191:138–42
49. Y.M.Hosakote, T.Liu, S.M.Castro,. (2009). Respiratory syncytial virus induces oxidative stress by modulating antioxidant enzymes. Am J Respir Cell Mol Biol 41:348–57
50. A.L.Hotard, S.Lee, M.G.Currier,. (2015). Identification of residues in the human respiratory syncytial virus fusion protein that modulate fusion activity and pathogenesis. J Virol 89:512–22
51. J.M.A.Hussman L.B.Paes, K.L.Lanctot. (2012). A review of cost-effectiveness of palivizumab for respiratory syncytial virus. Expert Rev Pharmacoecon Outcomes Res 12:553–567
52. S.Idell, U.Kucich, A.Fein,. (1985). Neutrophil elastase-releasing factors in bronchoalveolar lavage from patients with adult respiratory distress syndrome. Am Rev Respir Dis 132:1098–105
53. T.Ito, Y.H.Wang, O.Duramad,. (2005). TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med 202:1213–23
54. M.K.Iwane, K.M.Edwards, P.G.Szilagyi,. (2004). Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics 113:1758–64
55. M.Jamaluddin, B.Tian, I.Boldogh,. (2009). Respiratory syncytial virus infection induces a reactive oxygen species-MSK1-phospho-Ser-276 RelA pathway required for cytokine expression. J Virol 83:10605–15
56. K.M.James, R.S.PeeblesJr, T.V.Hartert. (2012). Response to infections in patients with asthma and atopic disease: an epiphenomenon or reflection of host susceptibility? J Allergy Clin Immunol 130:343–51
57. P.Janich, D.Corbeil. (2007). GM1 and GM3 gangliosides highlight distinct lipid microdomains within the apical domain of epithelial cells. FEBS Lett 581:1783–7
58. P.Jaovisidha, M.E.Peeples, A.A.Brees,. (1999). Respiratory syncytial virus stimulates neutrophil degranulation and chemokine release. J Immunol 163:2816–20
59. N.A.N.Jewell, S.E.Vaghefi, P.Mertz,. (2007). Differential type I interferon induction by respiratory syncytial virus and influenza a virus in vivo. J Virol 81:9790–800
60. H.Jin, X.Cheng, V.L.Traina-Dorge,. (2003). Evaluation of recombinant respiratory syncytial virus gene deletion mutants in African green monkeys for their potential as live attenuated vaccine candidates. Vaccine 21:3647–52
61. H.Jin, H.Zhou, X.Cheng,. (2000). Recombinant respiratory syncytial viruses with deletions in the NS1, NS2, SH, and M2–2 genes are attenuated in vitro and in vivo. Virology 273:210–18
62. J.E.Johnson, R.A.Gonzales, S.J.Olson,. (2007). The histopathology of fatal untreated human respiratory syncytial virus infection. Mod Pathol 20:108–19
63. T.R.Johnson, S.E.Mertz, N.Gitiban,. (2005). Role for innate IFNs in determining respiratory syncytial virus immunopathology. J Immunol 174:7234–41
64. G.E.Kaiko, S.Phipps, P.Angkasekwinai,. (2010). NK cell deficiency predisposes to viral-induced Th2-type allergic inflammation via epithelial-derived IL-25. J Immunol 185:4681–90
65. W.J.Karpus, N.W.Lukacs, K.J.Kennedy,. (1997). Differential CC chemokine-induced enhancement of T helper cell cytokine production. J Immunol 158:4129–36
66. C.K.Kim, C.S.Kim, B.I.Park,. (2003). Bronchoalveolar lavage cytokine profiles in acute asthma and acute bronchiolitis. J Allergy Clin Immunol 112:64–71
67. D.Kolli, T.S.Velayutham, A.Casola. (2013). Host-viral interactions: role of pattern recognition receptors (PRRs) in human pneumovirus infections. Pathogens 2:232--63
68. N.Krishnamoorthy, A.Khare, T.B.Oriss,. (2012). Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma. Nat Med 18:1525–30
69. S.Kristjansson, S.P.Bjarnarson, G.Wennergren,. (2005). Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local TH2-like response. J Allergy Clin Immunol 116:805–11
70. T.Kurihara, G.Warr, J.Loy, R.Bravo. (1997). Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med 186:1757–62
71. E.A.Kurt-Jones, L.Popova, L.Kwinn,. (2000). Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 1:398–401
72. D.M.Lambert. (1988). Role of oligosaccharides in the structure and function of respiratory syncytial virus glycoproteins. Virology 164:458–66
73. C.L.Larranaga, S.L.Ampuero, V.F.Luchsinger,. (2009). Impaired immune response in severe human lower tract respiratory infection by respiratory syncytial virus. Pediatr Infect Dis J 28:867–73
74. M.K.Lay, P.F.Cespedes, C.E.Palavecino,. (2015). Human metapneumovirus infection activates the TSLP pathway which drives excessive pulmonary inflammation and viral replication in mice. Eur J Immunol; DOI: 10.1002/eji.201445021
75. M.K.Lay, P.A.Gonzalez, M.A.Leon,. (2013). Advances in understanding respiratory syncytial virus infection in airway epithelial cells and consequential effects on the immune response. Microbes Infect 15:230–42
76. H.C.Lee, M.B.Headley, Y.M.Loo,. (2012). Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection. J Allergy Clin Immunol 130:1187–96 e5
77. J.P.Legg, I.R.Hussain, J.A.Warner,. (2003). Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 168:633–9
78. B.Liang, S.Munir, E.Amaro-Carambot,. (2014). Chimeric bovine/human parainfluenza virus type 3 expressing RSV F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection. J Virol 88:4237--50
79. R.M.Liesman, U.J.Buchholz, C.L.Luongo,. (2014). RSV-encoded NS2 promotes epithelial cell shedding and distal airway obstruction. J Clin Invest 124:2219–33
80. P.Liu, M.Jamaluddin, K.Li,. (2007). Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells. J Virol 81:1401–11
81. Y.J.Liu, V.Soumelis, N.Watanabe,. (2007b). TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu Rev Immunol 25:193–219
82. M.Loetscher, B.Gerber, P.Loetscher,. (1996). Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 184:963–9
83. M.Luevano, M.Daryouzeh, R.Alnabhan,. (2012). The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation. Hum Immunol 73:248–57
84. N.W.Lukacs, J.J.Smit, S.Mukherjee,. (2010). Respiratory virus-induced TLR7 activation controls IL-17-associated increased mucus via IL-23 regulation. J Immunol 185:2231–9
85. N.Marr, T.I.Wang, S.H.Kam,. (2014). Attenuation of respiratory syncytial virus-induced and RIG-I-dependent type I IFN responses in human neonates and very young children. J Immunol 192:948–57
86. P.Mastrangelo, R.G.Hegele. (2013). RSV fusion: time for a new model. Viruses 5:873–85
87. J.G.Mastronarde, B.He, M.M.Monick,. (1996). Induction of interleukin (IL)-8 gene expression by respiratory syncytial virus involves activation of nuclear factor (NF)-kappa B and NF-IL-6. J Infect Dis 174:262–7
88. K.Mcintosh. (1978). Interferon in nasal secretions from infants with viral respiratory tract infections. J Pediatr 93:33–6
89. J.S.McLellan, M.Chen, M.G.Joyce,. (2013). Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus. Science 342:592–8
90. P.S.McNamara, B.F.Flanagan, C.A.Hart, R.L.Smyth. (2005). Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis. J Infect Dis 191:1225–32
91. P.S.McNamara, B.F.Flanagan, A.M.Selby,. (2004). Pro- and anti-inflammatory responses in respiratory syncytial virus bronchiolitis. Eur Respir J 23:106–12
92. M.M.Miazgowicz, M.S.Elliott, J.S.Debley, S.F.Ziegler. (2013). Respiratory syncytial virus induces functional thymic stromal lymphopoietin receptor in airway epithelial cells. J Inflamm Res 6:53–61
93. A.L.Miller, R.M.Strieter, A.D.Gruber,. (2003). CXCR2 regulates respiratory syncytial virus-induced airway hyperreactivity and mucus overproduction. J Immunol 170:3348–56
94. S.S.Mohapatra, S.Boyapalle. (2008). Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma. Clin Microbiol Rev 21:495–504
95. M.M.Monick, T.O.Yarovinsky, L.S.Powers,. (2003). Respiratory syncytial virus up-regulates TLR4 and sensitizes airway epithelial cells to endotoxin. J Biol Chem 278:53035–44
96. A.S.Monto. (2002). Epidemiology of viral respiratory infections. Am J Med 112:4S–12S
97. S.H.Morichi, H.Kawashima, G.Ioi,. (2011). Classification of acute encephalopathy in respiratory syncytial virus infection. J Infect Chemother 17:776–81
98. K.Y.Moriyama, D.Takahashi, T.Shiihara. (2014). Another case of respiratory syncytial virus-related limbic encephalitis. Neuroradiology 56:435–6
99. S.Munir, P.Hillyer, C.Le Nouen,. (2011). Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response. PLoS Pathog 7:e1001336
100. S.Munir, C.Le Nouen, C.Luongo,. (2008). Nonstructural proteins 1 and 2 of respiratory syncytial virus suppress maturation of human dendritic cells. J Virol 82:8780–96
101. H.Nair, D.J.Nokes, B.D.Gessner,. (2010). Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375:1545–55
102. K.A.Neilson, E.J.Yunis. (1990). Demonstration of respiratory syncytial virus in an autopsy series. Pediatr Pathol 10:491–502
103. C.M.Oshansky, J.P.Barber, J.Crabtree, R.A.Tripp. (2010). Respiratory syncytial virus F and G proteins induce interleukin 1alpha, CC, and CXC chemokine responses by normal human bronchoepithelial cells. J Infect Dis 201:1201–7
104. C.M.Oshansky, T.M.Krunkosky, J.Barber,. (2009). Respiratory syncytial virus proteins modulate suppressors of cytokine signaling 1 and 3 and the type I interferon response to infection by a toll-like receptor pathway. Viral Immunol 22:147–61
105. A.Pichlmair, O.Schulz, C.P.Tan,. (2006). RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 314:997–1001
106. D.Prefontaine, S.Lajoie-Kadoch, S.Foley,. (2009). Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J Immunol 183:5094–103
107. J.Qiao, A.Li, X.Jin. (2011). TSLP from RSV-stimulated rat airway epithelial cells activates myeloid dendritic cells. Immunol Cell Biol 89:231–8
108. K.Reimers, K.Buchholz, H.Werchau. (2005). Respiratory syncytial virus M2–1 protein induces the activation of nuclear factor kappa B. Virology 331:260–8
109. T.Ren, Z.K.Wen, Z.M.Liu,. (2007). Functional expression of TLR9 is associated to the metastatic potential of human lung cancer cell: functional active role of TLR9 on tumor metastasis. Cancer Biol Ther 6:1704–9
110. R.F.Robinson. (2008). Impact of respiratory syncytial virus in the United States. Am J Health-Syst Pharm 65:S3–6
111. T.J.Ruckwardt, A.M.Malloy, K.M.Morabito, B.S.Graham. (2014). Quantitative and qualitative deficits in neonatal lung-migratory dendritic cells impact the generation of the CD8+ T cell response. PLoS Pathog 10:e1003934
112. I.Rudan, K.L.O'Brien, H.Nair,. (2013). Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries. J Glob Health 3:010401
113. B.D.Rudd, E.Burstein, C.S.Duckett,. (2005). Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. J Virol 79:3350–7
114. F.Sallusto, D.Lenig, C.R.Mackay, A.Lanzavecchia. (1998). Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 187:875–83
115. C.E.Samuel. (2001). Antiviral actions of interferons. Clin Microbiol Rev 14:778–809; table of contents
116. H.San-Juan-Vergara, V.Sampayo-Escobar, N.Reyes,. (2012). Cholesterol-rich microdomains as docking platforms for respiratory syncytial virus in normal human bronchial epithelial cells. J Virol 86:1832–43
117. M.G.Semple, H.M.Dankert, B.Ebrahimi,. (2007). Severe respiratory syncytial virus bronchiolitis in infants is associated with reduced airway interferon gamma and substance P. PLoS One 2:e1038
118. A.Shakeri, P.Mastrangelo, J.K.Griffin,. (2014). Respiratory syncytial virus receptor expression in the mouse and viral tropism. Histol Histopathol 30:401--11
119. T.Shibata, D.M.Habiel, A.L.Coelho,. (2014). Axl receptor blockade ameliorates pulmonary pathology resulting from primary viral infection and viral exacerbation of asthma. J Immunol 192:3569–81
120. M.Shingai, M.Azuma, T.Ebihara,. (2008). Soluble G protein of respiratory syncytial virus inhibits Toll-like receptor 3/4-mediated IFN-beta induction. Int Immunol 20:1169–80
121. N.Sigurs, F.Aljassim, B.Kjellman,. (2010). Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax 65:1045–52
122. N.Sigurs, R.Bjarnason, F.Sigurbergsson, B.Kjellman. (2000). Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 161:1501–7
123. N.Sigurs, P.M.Gustafsson, R.Bjarnason,. (2005). Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 171:137–41
124. D.E.Smith. (2010). IL-33: a tissue derived cytokine pathway involved in allergic inflammation and asthma. Clin Exp Allergy 40:200–8
125. V.Soumelis, P.A.Reche, H.Kanzler,. (2002). Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 3:673–80
126. K.M.Spann, K.C.Tran, B.Chi,. (2004). Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]. J Virol 78:4363–9
127. K.M.Spann, K.C.Tran, P.L.Collins. (2005). Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-kappaB, and proinflammatory cytokines. J Virol 79:5353–62
128. L.G.Stensballe, J.B.Simonsen, S.F.Thomsen,. (2009). The causal direction in the association between respiratory syncytial virus hospitalization and asthma. J Allergy Clin Immunol 123:131–7 e1
129. M.T.Stier, K.Goleniewska, R.S.Peebles. (2014). Respiratory syncytial virus induces IL-25 and IL-33 production in the lungs. J Allergy Clin Immunol 133:AB53
130. K.L.Stokes, M.G.Currier, K.Sakamoto,. (2013). The respiratory syncytial virus fusion protein and neutrophils mediate the airway mucin response to pathogenic respiratory syncytial virus infection. J Virol 87:10070–82
131. D.D.Taub, A.R.Lloyd, K.Conlon,. (1993). Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med 177:1809–14
132. D.D.Taub, D.L.Longo, W.J.Murphy. (1996). Human interferon-inducible protein-10 induces mononuclear cell infiltration in mice and promotes the migration of human T lymphocytes into the peripheral tissues and human peripheral blood lymphocytes-SCID mice. Blood 87:1423–31
133. D.D.Taub, T.J.Sayers, C.R.Carter, J.R.Ortaldo. (1995). Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J Immunol 155:3877–88
134. L.M.Taussig, A.L.Wright, C.J.Holberg,. (2003). Tucson children's respiratory study: 1980 to present. J Allergy Clin Immunol 111:661–75; quiz 676
135. F.Tayyari, D.Marchant, T.J.Moraes,. (2011). Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat Med 17:1132–5
136. M.N.Teng, S.S.Whitehead, P.L.Collins. (2001). Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo. Virology 289:283–96
137. The_IMpact-RSV_Study_Group. (1998). Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102:531–7
138. S.F.Thomsen, S.van der Sluis, L.G.Stensballe,. (2009). Exploring the association between severe respiratory syncytial virus infection and asthma: a registry-based twin study. Am J Respir Crit Care Med 179:1091–7
139. T.S.Velayutham, D.Kolli, T.Ivanciuc,. (2013). Critical role of TLR4 in human metapneumovirus mediated innate immune responses and disease pathogenesis. PLoS One 8:e78849
140. R.Villenave, M.D.Shields, U.F.Power. (2013). Respiratory syncytial virus interaction with human airway epithelium. Trends Microbiol 21:238–44
141. R.Villenave, S.Thavagnanam, S.Sarlang,. (2012). In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo. Proc Natl Acad Sci USA 109:5040–5
142. T.P.Welliver, R.P.Garofalo, Y.Hosakote,. (2007). Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis 195:1126–36
143. P.Wu, T.V.Hartert. (2011). Evidence for a causal relationship between respiratory syncytial virus infection and asthma. Expert Rev Anti Infect Ther 9:731–45
144. H.Xie, Y.C.Lim, F.W.Luscinskas, A.H.Lichtman. (1999). Acquisition of selectin binding and peripheral homing properties by CD4(+) and CD8(+) T cells. J Exp Med 189:1765–76
145. X.H.Xie, H.K.Law, L.J.Wang,. (2009). Lipopolysaccharide induces IL-6 production in respiratory syncytial virus-infected airway epithelial cells through the toll-like receptor 4 signaling pathway. Pediatr Res 65:156–62
146. Y.Yamaguchi, Y.Hayashi, Y.Sugama,. (1988). Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J Exp Med 167:1737–42
147. L.Zhang, M.E.Peeples, R.C.Boucher,. (2002). Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J Virol 76:5654–66
148. L.Zhang, A.Bukreyev, C.I.Thompson,. (2005). Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium. J Virol 79:1113–24
149. Z.R.J.Zhu, Z.Homer, Q.Wang,. (1999). Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 103:779–88